Empagliflozin + Metformin

DRUG2 trials

Sponsors

Boehringer Ingelheim, University of Lahore

Conditions

Diabetes MellitusHealthy

Phase 1

Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets

CompletedNCT01672788

Boehringer IngelheimHealthy

Start: 2012-08-31End: 2012-11-30Updated: 2015-08-31

Phase 3

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

CompletedNCT06952231

University of LahoreDiabetes Mellitus

Start: 2024-05-21End: 2025-01-05Updated: 2025-04-30